Texas Bank & Trust’s DexCom DXCM Stock Holding History

Texas Bank & Trust’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$220K	Hold	3,500	–	–	0.08%	169
2025 Q4	$232K	Buy	+3,500	New	+$226K	0.08%	167

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Texas Bank & Trust's DXCM Position: Q1 2026 in Review

Texas Bank & Trust held its DexCom (DXCM) position steady in Q1 2026 at 3,500 shares worth $220K. The position accounts for 0.08% of the portfolio, ranked #169.

Texas Bank & Trust first reported a position in DXCM in Q4 2025 and has held it in 2 quarters since. The position peaked at $232K in Q4 2025. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Texas Bank & Trust held 3,500 shares of DexCom worth $220K as of Q1 2026.
Texas Bank & Trust left its DexCom share count unchanged in Q1 2026.
DexCom made up 0.08% of Texas Bank & Trust's portfolio in Q1 2026, its #169 holding.
Texas Bank & Trust first reported a position in DexCom in Q4 2025 and has held it in 2 quarters since.
Texas Bank & Trust's DexCom position peaked at $232K in Q4 2025.
957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Texas Bank & Trust's 13F filing for Q1 2026, filed 30 Apr 2026.